A Case Study of Sequential Myeloid Sarcoma in the Nasal Cavity and Breast with a 6-Year Interval: Insights from Literature - Scorecard - MDSpire

A Case Study of Sequential Myeloid Sarcoma in the Nasal Cavity and Breast with a 6-Year Interval: Insights from Literature

  • By

  • Jiaxin Yu

  • Chuanlin Hou

  • Feng Xu

  • April 28, 2026

  • 0 min

Share

Clinical Scorecard: A Case Study of Sequential Myeloid Sarcoma in the Nasal Cavity and Breast with a 6-Year Interval: Insights from Literature

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPatients with a history of acute myeloid leukemia or myelodysplastic syndromes, noting the rarity in those without.
Care Setting

Key Highlights

  • Add a highlight about the importance of distinguishing MS from other malignancies.

Guideline-Based Recommendations

Diagnosis

  • Utilize comprehensive immunohistochemical panels including myeloid-specific markers such as CD117 and MPO.

Management

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Provide details on dosages and duration of localized radiotherapy and chemotherapy.

        Clinical Best Practices

        • Incorporate follow-up imaging protocols to monitor for recurrence.

        References

        Original Source(s)

        A Case Study of Sequential Myeloid Sarcoma in the Nasal Cavity and Breast with a 6-Year Interval: Insights from Literature

        • by Jiaxin Yu, Chuanlin Hou, Feng Xu

        • April 28, 2026

        Related Content

        Beyond the tumor: the role of the gut microbiome in triple-negative breast cancer

        Glandular tissue–based versus anatomical landmark–based CTV delineation in postoperative breast cancer radiotherapy: a dosimetric comparison

        Case Report: A case of a pregnancy-associated breast cancer patient with a pathogenic variant in BRCA1 who underwent staged risk-reducing salpingo-oophorectomy and contralateral risk-reducing mastectomy